Marc D. Beer, Chief Executive Officer at Aegerion Pharmaceuticals, Inc. (AEGR), bought 5,332 shares at $18.73 ($100K) on 2011-06-01, disclosed to the SEC on 2011-06-03.
Scheduled purchase ($100k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.69 | 4,162 | $78K | 78.0% |
| 2 | $18.73 | 1,170 | $22K | 22.0% |
| Total | $18.70 avg | 5,332 | $100K | 100% |
| Filing → |
| BTMD | SELL | 2023-01-10 | $2.6M | — | Filing → |
| NERV | BUY | 2017-03-21 | $406K | — | Filing → |
| AEGR | BUY | 2014-07-31 | $337K | — | Filing → |